Literature DB >> 16430345

Olfactory function in oncologic hospice patients.

Arkadi Yakirevitch1, Michaela Bercovici, Lela Migirov, Abraham Adunsky, M Raphael Pfeffer, Jona Kronenberg, Yoav P Talmi.   

Abstract

INTRODUCTION: Normal sense of smell is important for well being. Although cancer is reported to be associated with impaired olfactory function, very few studies have directly evaluated this effect. PATIENTS AND METHODS: We performed a quantitative analysis of olfactory status in 42 hospice patients in a hospital-based hospice facility. Olfaction was assessed using the "Sniffin' Sticks" (Burghart Medical Technology, Tinsdaler, Germany) kit.
RESULTS: Twenty-five patients (60%) were found to be hyposmic.
CONCLUSION: Study results indicate the high incidence of decreased olfactory function among hospice patients.

Entities:  

Mesh:

Year:  2006        PMID: 16430345     DOI: 10.1089/jpm.2006.9.57

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  4 in total

1.  The experience of dysgeusia in allogeneic haematopoietic cell transplantation survivors: a qualitative study.

Authors:  Davide Bomben; Alessandra Bin; Margherita Venturini; Teresa Bulfone; Luca Ghirotto; Valentina Bressan
Journal:  Support Care Cancer       Date:  2019-04-01       Impact factor: 3.603

Review 2.  A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients.

Authors:  Trina Thorne; Karin Olson; Wendy Wismer
Journal:  Support Care Cancer       Date:  2015-07-11       Impact factor: 3.603

Review 3.  Smell and taste in palliative care: a systematic analysis of literature.

Authors:  Maria Heckel; Stephanie Stiel; Christoph Ostgathe
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-05       Impact factor: 2.503

4.  Taste and Smell Function in Head and Neck Cancer Survivors.

Authors:  Raul Alfaro; Sylvia Crowder; Kalika P Sarma; Anna E Arthur; Marta Yanina Pepino
Journal:  Chem Senses       Date:  2021-01-01       Impact factor: 4.985

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.